Supply:
Ranidin 150 Tablet : Box containing 10 x 15 tablets in Alu-Alu blister strips.
Ranidin Syrup : Bottle containing 100 ml syrup with a measuring cup.
Ranidin Injection: Box containing 2 x 5 ampoules in blister
Composition:
Ranidin 150 Tablet : Each film-coated tablet contains Ranitidine Hydrochloride USP equivalent to Ranitidine 150 mg.
Ranidin Syrup : Each 5 ml syrup contains Ranitidine (as Hydrochloride) USP 75 mg.
Ranidin Injection : Each 2 ml ampoule contains Ranitidine Hydrochloride USP 55.8 mg equivalent to 50 mg Ranitidine.
Indications:
Benign gastric and duodenal ulcer, Reflux esophagitis, NSAID-associated ulceration, Chronic episodic dyspepsia, Zollinger-Ellison syndrome, Gastric acid reduction (prophylaxis of acid aspiration) in obstetrics and in surgical procedures.
Dosage and Administration:
Tablet & Syrup: Benign gastric and duodenal ulcer: 150 mg (2 teaspoonful) twice daily or 300 mg (4 teaspoonful) at night for 4-8 weeks. Maintenance dose: 150 mg (2 teaspoonful) at night. Reflux esophagitis: 150 mg (2 teaspoonful) twice daily or 300 mg (4 teaspoonful) at night for up to 8 weeks or if necessary 12 weeks [moderate to severe, 150 mg (2 teaspoonful) 4 times daily for up to 12 weeks]. Long-term treatment of healed esophagitis: 150 mg (2 teaspoonful) twice daily. Zollinger-Ellison syndrome: 150 mg (2 teaspoonful) 3 times daily; doses up to 6 g daily in divided doses can be used. NSAID-associated ulceration: 150 mg (2 teaspoonful) twice daily or 300 mg (4 teaspoonful) at night for up to 8 weeks. Prophylaxis of NSAID-induced duodenal ulcer: 150 mg (2 teaspoonful) twice daily. Chronic episodic dyspepsia: 150 mg (2 teaspoonful) twice daily or 300 mg (4 teaspoonful) at night for up to 6 weeks. Gastric acid reduction (prophylaxis of acid aspiration) in obstetrics: 150 mg (2 teaspoonful) at onset of labour, then every 6 hours; Surgical procedures: 150 mg (2 teaspoonful) two hours before induction of anaesthesia, and if possible on the preceding evening.
Children (Peptic ulcer): 2-4 mg/kg twice daily to a maximum of 300 mg (4 teaspoonful) daily.
Injection: Ranidin injection is administered intramuscularly or intravenously. By intramuscular injection, 50 mg every 6-8 hours. By slow intravenous injection, 50 mg diluted to 20 ml and given over at least 2 minutes; may be repeated every 6-8 hours. By intravenous infusion, 25 mg/hour for 2 hours; may be repeated every 6-8 hours. Prophylaxis of stress ulceration, initial slow intravenous injection of 50 mg then continuous infusion, 0.125-0.250 mg/kg/hour. Surgical procedures, by intramuscular or intravenous injection, 50 mg 45-60 minutes before induction of anesthesia (intravenous injection diluted to 20 ml and given over at least 2 minutes).
OR AS DIRECTED BY THE PHYSICIAN.
